Vimarsana
Biggest News Aggregation in the World

Page 34 - Ipca Laboratories News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ipca Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ipca Laboratories Today - Breaking & Trending Today

Indices: Stock market update: Nifty Pharma index falls 0.19% - Vimarsana News

Indices: Stock market update: Nifty Pharma index falls 0.19%

The Nifty Pharma index closed 0.19 per cent down at 13238.85.

Trade setup for Monday: Top 15 things to know before the opening bell - Vimarsana News

Trade setup for Monday: Top 15 things to know before the opening bell

Based on the OI percentage, 87 stocks including Oracle Financial, Dr Lal PathLabs, LTIMindtree, Metropolis Healthcare, and Ashok Leyland saw a long build-up.

Trade setup for Friday: Top 15 things to know before the opening bell - Vimarsana News

Trade setup for Friday: Top 15 things to know before the opening bell

Based on the OI percentage, 63 stocks including Tata Chemicals, Dr Lal PathLabs, Wipro, Federal Bank and State Bank of India saw a short build-up.

ipca lab share price: Ipca Labs falls 3% after USFDA issues Form 483 to API unit - Vimarsana News

ipca lab share price: Ipca Labs falls 3% after USFDA issues Form 483 to API unit

Shares of Indian pharmaceutical company, Ipca Laboratories, fell by 3% after the US Food and Drug Administration (USFDA) issued a Form 483 report, citing 11 observations of its API manufacturing facility situated in Ratlam. Form 483 is issued when an inspector has found conditions that could violate FDA regulations. Ipca said it takes quality and compliance issues seriously and will submit a response in the prescribed time. Trendlyne data showed that the stock's day RSI (14) is at 57.8, while the MACD is above its center and signal line, which is a bullish indicator.

Ipca Laboratories Ltd gets Form 483 with 11 observations for API manufacturing facility at Ratlam - Vimarsana News

Ipca Laboratories Ltd gets Form 483 with 11 observations for API manufacturing facility at Ratlam

The US FDA issued a Form 483 with 11 observations to Ipca Laboratories Ltd after conclusion of inspection at API manufacturing facility situated at Ratlam, Madhya Pradesh.